In:
Cancer, Wiley, Vol. 116, No. 1 ( 2010-01), p. 251-255
Abstract:
The current study indicates that C57BL/6 receiving weekly intraperitoneal injections of oxaliplatin at a dose of 6 mg/kg up to a total dose of 24 mg/kg could be used as a model for chemotherapy‐associated steatohepatitis (CASH). Oral fatty acid bile acid conjugate therapy reduced the development of CASH in animals that were treated with oxaliplatin.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
Language:
English
Publisher:
Wiley
Publication Date:
2010
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink